Dr. Toby Maher

Biography

Toby Maher is the British Lung Foundation Chair in Respiratory Research at the National Institute for Health Research (NIHR) and a Clinician Scientist. He specializes in Interstitial Lung Disease and leads the Fibrosis Research Group at the National Heart and Lung Institute, Imperial College London. He has extensive clinical expertise in various forms of interstitial lung disease, including idiopathic pulmonary fibrosis (IPF) and hypersensitivity pneumonitis. Maher has established a clinical translational research program with a team of 15, focusing on biomarker discovery and conducting early-phase clinical trials. His ongoing research initiatives include the PROFILE study, a biomarker discovery program for IPF that has recruited 500 individuals, and the MRC EME funded RECITAL study, which evaluates Rituximab treatment for connective tissue disease-associated interstitial lung disease. He is also a Trustee of the British Lung Foundation and actively participates in several specialist societies. His editorial contributions span numerous prestigious journals, and he has served in various editorial capacities including as Associate Editor for the American Journal of Respiratory and Critical Care Medicine. Maher holds an MSc in Respiratory Medicine from Imperial College London and completed his PhD through a Wellcome Trust Clinical Research Fellowship at University College London.

Research Interests

Experience